Arrowhead Pharmaceuticals, Inc.
Status: Publicly traded
Direct answer
Arrowhead Pharmaceuticals, Inc. is publicly traded on NASDAQ under the ticker ARWR.
Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II...
Can you invest in Arrowhead Pharmaceuticals, Inc.?
Yes. Arrowhead Pharmaceuticals, Inc. trades publicly on NASDAQ as ARWR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Arrowhead Pharmaceuticals, Inc.
Detailed equity research is provided by MarketSnap.